Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART | 80 |
| Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART | 60 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART | 5 | 3 | 7 | 0 | 6 | 11 | 8 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 76 |
| Australia | 11 |
| France | 9 |
| China | 8 |
| Netherlands | 8 |
| Vietnam | 5 |
| Singapore | 4 |
| Argentina | 3 |
| Lithuania | 3 |
| Hong Kong SAR China | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 24 |
| Fairfield | 16 |
| Rotterdam | 8 |
| Kaleen | 7 |
| Cambridge | 6 |
| Hanoi | 5 |
| Boardman | 4 |
| Brisbane | 2 |
| Central | 2 |
| Hanover | 2 |